ADVM – adverum biotechnologies, inc. (US:NASDAQ)
Stock Stats
News
Adverum Biotechnologies Announces Appointments of Dr. Rabia Gurses Ozden as Chief Medical Officer and Dr. Szilárd Kiss as a Member of the Board of Directors [Yahoo! Finance]
Adverum Biotechnologies Announces Appointments of Dr. Rabia Gurses Ozden as Chief Medical Officer and Dr. Szilárd Kiss as a Member of the Board of Directors
Adverum Biotechnologies, Inc. (NASDAQ: ADVM) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Adverum Biotechnologies, Inc. (NASDAQ: ADVM) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $60.00 price target on the stock.
Adverum Biotechnologies: Q1 Earnings Snapshot [Yahoo! Finance]
Form DEFA14A Adverum Biotechnologies,
Form 8-K Adverum Biotechnologies, For: Jun 06
Form DEFA14A Adverum Biotechnologies,
Form SC 13D/A Adverum Biotechnologies, Filed by: Versant Ventures IV, LLC
Form 10-Q Adverum Biotechnologies, For: Mar 31
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.